SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950116-02-002569
Filing Date
2002-11-13
Accepted
2002-11-13 16:46:11
Documents
5
Period of Report
2002-07-31

Document Format Files

Seq Description Document Type Size
1 10-K ten-k.txt 10-K 344644
3 EXHIBIT 21 exh21.txt EX-21 539
4 EXHIBIT 23.1.1 exh23-1_1.txt EX-23 666
5 EXHIBIT 23.1.2 exh23-1_2.txt EX-23 674
6 EXHIBIT 99.1 exh99-1.txt EX-99 2026
  Complete submission text file 0000950116-02-002569.txt   350506
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 02820569
SIC: 2834 Pharmaceutical Preparations